Revenue Update on Pure Bioscience(OTCMKTS:PURE)

Pure Bioscience(OTCMKTS:PURE) announced the earnings results for Fiscal Year 2016 and Q3. The results came in during After-hours on Jun 9, 2016. Earnings per share were $-0.02.

Several Insider Transactions has been reported to the SEC. On Sep 9, 2015, David M Theno (director) purchased 34,000 shares at $0.75 per share price.Also, On Sep 9, 2015, David J Pfanzelter (director) purchased 40,000 shares at $0.75 per share price.On Sep 9, 2015, William Otis (director) purchased 22,666 shares at $0.75 per share price, according to the Form-4 filing with the securities and exchange commission.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Pure Bioscience - Is it time to Sell?

Top Brokerage Firms are advising their investors on Pure Bioscience. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.